体内分布
化学
神经降压素
癌症研究
Pet成像
受体
肺癌
受体表达
癌症
骨髓
泌尿系统
显像剂
分子成像
药代动力学
放射合成
肺
流式细胞术
放射性核素治疗
肿瘤细胞
细胞培养
细胞
标签
正电子发射断层摄影术
部分
锝-99m
细胞表面受体
肿瘤进展
基因表达
分子生物学
共轭体系
作者
Xiufeng Liu,Yang Chen,Jiamin Zhu,Wenqing Zhang,Kun Qian,Danyi Guo,Qi Guo,Peng Wang,Zhen Xiang Cheng,Hui Yuan,Lei Jiang
标识
DOI:10.1021/acs.molpharmaceut.5c01915
摘要
High neurotensin receptor 1 (NTSR1) expression is strongly associated with progression and poor prognosis across multiple malignancies. We designed an NTSR1-targeted peptide-based PET probe conjugated with the albumin-binding moiety ibuprofen, designated [ 68 Ga]Ga-DOTA-NT-20.3-Ibu, which was synthesized with high radiochemical yield and purity, exhibited sufficient in vitro stability, and demonstrated favorable serum albumin-binding capacity. Cell binding/uptake assays, animal-based PET imaging, and biodistribution studies confirmed the radiotracer’s high affinity and specificity for NTSR1. In human participants, [ 68 Ga]Ga-DOTA-NT-20.3-Ibu was safe and primarily excreted via the urinary system. Bone marrow uptake was detectable with SUVmean of 4.11 ± 1.59 and 4.99 ± 1.82 at 60 and 120 min postinjection, respectively. Mild uptake was observed in the blood pool, liver, spleen, pancreas, stomach, and bowel, while other tissues showed minimal uptake. Importantly, lung tumor uptake of [ 68 Ga]Ga-DOTA-NT-20.3-Ibu correlated with NTSR1 expression levels. Collectively, [ 68 Ga]Ga-DOTA-NT-20.3-Ibu PET enables accurate, noninvasive assessment of tumor NTSR1 expression, facilitating NTSR1-targeted cancer treatment and prognosis monitoring.
科研通智能强力驱动
Strongly Powered by AbleSci AI